ABSTRACT Throughout the world, expanded spectrum β-lactamases (ESBL) are increasing among clinical isolates of Enterobacteriaceae, both in humans and animals. Unfortunately, there is a paucity of data on ESBL or Ampicillin class C β-lactamase (AmpC) in Egypt, although antimicrobial consumption is high in this developing country. This study aims to characterize the resistance mechanisms to expanded spectrum cephalosporins among resistant veterinary Escherichia coli isolates in Egypt. We investigated 50 clinical multi-resistant E. coli strains isolated from 20 chicken farms for production of ESBL or AmpC. Antibiotic susceptibility was tested by Clinical and Laboratory Standards Institute (CLSI) disk diffusion and ESBL confirmatory tests. PCR and sequencing were performed to screen for plasmid mediated ESBL genes and genes encoding AmpC β-lactamases. All the isolates were phylogentically classified, investigated for harboring class 1 integrons, and genotyped by amplified fragment length polymorphism (AFLP). Three strains showed ESBL and 6 strains AmpC phenotypic patterns, respectively, with confirmed ESBL genes of bla , bla , bla CTX-M-14 , and bla CMY-2 for AmpC producing strains. All ESBL strains belonged to phylogroup D with different clones isolated from different flocks, while most of the AmpC strains belonged to phylogroup B1 (4/6) and were assigned to the same genotype distributed in 2 different farms. Class 1 integrons were disseminated in 60% of all tested strains and in 100% of ESBL and AmpC strains. These results highlight the antimicrobial resistance problem in Egypt, caused in all probability by unwise use of antimicrobials in animal husbandry. The results call for a nationwide surveillance program to monitor antimicrobial resistance.
INTRODUCTION
The predominant cause of resistance to β-lactam antibiotics in Gram-negative bacteria is production of β-lactamases, which inactivate β-lactams by hydrolysing the 4-membered β-lactam ring (Ambler, 1980) . Extended spectrum β-lactamases (ESBL) are derived from the point mutations in the bla TEM-1 and bla SHV-1 β-lactamase genes (Bush et al., 1995) . During the last decade, another type of ESBL encoded by bla CTX-M has emerged worldwide (Livermore et al., 2007) . By definition, ESBL producing organisms confer resistance to penicillin, oxyiminocephalosporins, and monobactams. They cannot hydrolyse cephamycins and are inhibited by clavulanic acid (CA) (Bush C and Jacoby, 2010) . Ampicillin class C β-lactamase (AmpC) enzymes are active on cephamycins as well as oxyiminocephalosporins and monobactams (Jacoby, 2009) . Boronic acid (BA) derivatives have been reported to be reversible inhibitors of AmpC enzymes (Beesley et al., 1983) . One of the main concerns is that the genes encoding these expanded spectrum ß-lactamases are mostly located on mobile genetic elements (e.g., plasmids or integrons), which can easily be mobilized to other bacteria and other bacterial species by horizontal gene transfer (Pfeifer et al., 2010) . Resistance caused by these enzymes may spread to pathogenic bacteria, resulting in reduced efficacy of the therapeutic compound or more frequent treatment failures when employing broad spectrum β-lactams as one of the frontline treatments in human medicine (Dutil et al., 2010) .
Enterobacteriaceae coding for expanded spectrum β-lactamases are significant pathogens in nosocomial infections and have become a topic of global 2375 concern in both farm animals and humans (Bradford, 2001) . Pathogenic E. coli derived from poultry (avian pathogenic E.coli), which cause an extraintestinal infection called colibacillosis, and human extra-intestinal pathogenic E. coli (ExPEC) can possess similar antimicrobial resistance patterns and/or resistance genes (Johnson et al., 2006; Jakobsen et al., 2010b) . Many of the human ExPEC strains may have a food animal source, suggesting transmission to humans via the food supply (Manges and Johnson, 2012) . The public health community should pay attention to the growing body of evidence supporting foodborne transmission, especially from poultry, since poultry meat exhibits the highest overall levels of E. coli contamination (Manges and Johnson, 2012) . These can be more extensively antimicrobial resistant than E. coli recovered from other meats (CIPARS, 2011; NARMS, 2011) . In Egypt, hospital surveillance data obtained from 2002 to 2010 on human E. coli isolates showed resistance rates of 38.7 and 50.1% against ceftazidime and ceftriaxone, respectively (WHO, 2014) .
Our objectives were to investigate (1) phenotypically and genetically the prevalence of ESBL and AmpC producers in a collection of multi-resistant E. coli isolated from 20 broiler farms in Egypt, (2) to genotype these isolates and screen for the presence of class 1 integrons as mobile genetic elements, and (3) to determine their possible contributions to resistance and resistance gene transfer. This procedure can provide a better understanding of the spread of antimicrobial resistant E. coli and epidemiological association with chickens as foodproducing animals in an area that has not as yet benefited from a national surveillance system and is affected by sparse data in the presence of high antimicrobial consumption.
MATERIALS AND METHODS

Collection of Samples
Between May and July 2012, samples (liver and heart) were aseptically collected from 20 small-scale commercial broiler farms (2,500 to 8,000 birds) distributed throughout 4 different cities in EgyptIsmailia, Port Said, Suez, and Areesh. The diseased broilers were suffering from respiratory distress, coughing, ruffled feather, diarrhea, reduced appetite, and poor growth and were unresponsive to antimicrobial treatment such as penicillin, streptomycin, doxycycline, gentamicin, or ciprofloxacin. Postmortem examination revealed perihepatitis, pericarditis, airsaculitis, enteritis, and, occasionally, pneumonia. All samples were directly transported to the laboratory and processed immediately.
Tracheal and cloacal swabs were collected from all diseased chickens subjected to bacterial isolation. All swabs were tested by RT-PCR and proved negative for detection of avian influenza virus (AIV), Newcastle disease virus (NDV), infectious bronchitis virus (IBV), infectious laryngotracheitis virus (ILTV), avian metapneumovirus (aMPV), and Mycoplasma gallisepticum (MG).
Isolation and Identification
The collected and prepared samples were enriched in buffered peptone water (Lab M Limited, Lancashire, UK) by incubation at 37
• C for 18 to 24 hours. After enrichment, a loopful from the incubated broth was streaked directly onto eosin methylene blue agar (Lab, UK) and incubated at 37
• C for 18 to 24 hours. Colonies producing metallic sheen were subjected for further biochemical in-house tests by means of Gram staining, detection of motility, cytochrome oxidase, indole production, methyl-red, Voges-Proskauer, citrate utilization, urea hydrolysis, sugar fermentation, hydrogen sulfide production, and gelatine liquefaction (Quinn et al., 1994) . Bacterial species determination was confirmed entirely by use of a MALDI-TOF MS Biotyper (Bruker Daltonik GmbH, Bremen, Germany).
In vivo Pathogenicity Testing
Based on the severity of symptoms and lesions, 6 selected strains were tested by inoculating groups of 5 one-day-old chicks subcutaneously with 0.5 mL of an overnight culture in LB broth. The inoculum consisted of 10 8 CFU in stationary phase and the mortality was recorded 4 d post inoculation. Strains were classified as pathogenic if at least one chick died (Schouler et al., 2012) . Pathogenicity index was given values 0 to 5, whereby 0 stood for zero mortality and 5 for 100% mortality. A control group was inoculated with 0.5 mL of LB broth by the same route. Dead birds were collected for necropsy and macroscopic evaluation of the lesions. Surviving birds were subjected to bacterial isolation from the liver and heart.
Antimicrobial Susceptibility
All E. coli isolates were tested by agar diffusion for antimicrobial susceptibility against ciprofloxacin, gentamicin, streptomycin, and ampicillin (HiMedia Laboratories, Mumbai, India), as well as cefazolin, doxycycline, cotrimoxazole, and ertapenem (Oxoid, Basingstoke, UK) according to Clinical and Laboratory Standards Institute (CLSI) guidelines and were clinically categorized with breakpoints (CLSI, 2012a; CLSI, 2014) . Fifty strains of the 70 E. coli isolates recovered in the study (71.4%) were multi-resistant, i.e., resistant to at least one agent in 3 or more antimicrobial categories (Magiorakos et al., 2012) . All intermediate strains were considered to be non-susceptible strains; each intermediate strain was resistant to at least 3 antimicrobial categories other than the category against which it was tested.
Phenotypic ESBL and AmpC Testing
Confirmed multi-resistant E. coli strains (n = 50) were screened for ESBL production by initial and confirmatory testing using cefotaxime and ceftazidime disks with and without clavulanic acid (Mast Diagnostics, Merseyside, UK) (CLSI, 2014) . Klebsiella pneumoniae ATCC 700603 and E. coli ATCC 25922 were used as positive and negative quality control strains, respectively. Furthermore, cefoxitin disks (Becton Dickinson, Heidelberg, Germany) with and without boronic acid (400 μg, Sigma-Aldrich Chemie, Taufkirchen, Germany) were used to detect AmpC phenotypes (Coudron, 2005) . All isolates classified as resistant to cefoxitin using CLSI criteria were suspected to be AmpC producers, which was confirmed by an increased inhibition zone of at least 5 mm in the presence of boronic acid.
MIC Determination
MIC was determined for all multi-resistant strains and both transconjugants using a 2-fold agar dilution plate method for cefotaxime, ceftazidime, and cefoxitin powders as previously described (CLSI, 2012b) regarding the breakpoints and normal ranges of control strains used (E. coli ATCC 25922, Staphylococcus aureus ATCC 29213, K. pneumonia ATCC 700603, and Staphylococcus aureus ATCC 43300) (CLSI, 2014).
PCR Screening for Gesistance Genes
All ESBL (n = 3) and AmpC (n = 6) positive strains and the corresponding transconjugants (n = 2) were screened by PCR amplification for the ESBL genes (bla TEM , bla SHV , and bla CTX-M ) and genes encoding AmpC β-lactamases (FOX, LAT, CMY, BIL, MOX, DHA, MIR, and ACT) using AmpliTaq Gold DNA Polymerase (Applied Biosystems, Darmstadt, Germany). Positive samples for bla CTX-M were re-amplified using primers specific for either bla CTX-M group 1, 2, 8, or group 9. The primers used for PCR amplification are detailed in Table S1 (available as supplementary data).
Sequence Analysis of Amplicons
All positive PCR products were purified and subjected to direct sequencing on both strands with (ABI PRISM 310 Genetic Analyzer, Applied Biosystems) using the same primers used before for PCR and BigDye Terminator cycle sequencing Kit (Applied biosystems) in order to unequivocally confirm the presence of ESBL and AmpC genes in these samples. The nucleotide sequences were analyzed by use of Staden package software, Pregap4 v.1.6-r and Gap4 v 4.11.2-r (Staden et al., 2000) . The BLAST program of NCBI (http://blast.ncbi.nlm.nih.gov/) and ß-lactamase classification and amino acid sequences for TEM, SHV, and other extended spectrum and inhibitor resistant enzymes were used for database comparison (http://www.ncbi.nlm.nih. gov/projects/pathogens/submit beta lactamase) employing EMBL-EBI/Clustal Omega http://www.ebi.ac. uk/Tools/msa/clustalo/.
Transconjugation Assay
The conjugation assay was conducted to determine whether the detected resistance genes and the class 1 integrons were transferable to a recipient E. coli. Conjugation experiments were performed by the filter-mating technique (Wang et al., 2003) using the proven ESBL or AmpC E. coli strains of this study as donor strains and a rifampicin and Na-azide resistant E. coli J53 (kindly provided by G. Jacoby, Lahey Clinic) as recipient.
Detection of Class 1 Integrons
PCR using genomic DNA was performed for all 50 strains and the corresponding transconjugants as the template (Martinez-Freijo et al., 1998) . The primers and conditions used for detection of integrons are summarized in Table S1 .
Phylogentic Grouping of E. coli Strains
All 50 E. coli isolates and both transconjugants were grouped phylogenetically by using a modified triplex PCR (Clermont et al., 2000) . In brief, gene fragments of chuA and yjaA and a DNA fragment TSPE4.C2 were amplified with primers and conditions (shown in Table S1 ). PCR reaction was done using Taq DNA polymerase (Roche, Germany). Strains were assigned to phylogenetic groups in accordance to presence or absence of the 3 amplicons.
Genotyping by Amplified Fragment Length Polymorphism
Amplified fragment length polymorphism (AFLP) was used as previously described (Arnold et al., 1999) . Strains of the same phylogenetic group were compared and were assigned to different genotypes in the presence of at least 3 fragment differences.
RESULTS
Epidemiological Data of the Isolates
Fifty strains collected from 5 breeds of birds diseased with colibacillosis on 20 commercial farms in 4 different cities in Egypt were isolated during the period May to July 2012. Epidemiological descriptions of all 50 E. coli strains are shown in Table 1 . Table 1 . Epidemiology and genotypic description of E. coli isolated from diseased chickens in the year 2012. The first letter of the farm code indicates the cities Ismailia (I), Port Said (P), Areesh (A), and Suez (S). The pathogenicity index is given for selected strains. 
In vivo Pathogenicity Testing
Mortalities in one-day-old chicks ranged from 40 to 100% in 24 to 96 h, which corresponds to pathogenicity indexes of 2 to 5 (Table 1) . Clinical symptoms shown by sick birds before they died were vents pasted with feces, depression, lameness, ruffled feathers, and weakness. Postmortem findings indicated congested and enlarged livers, hearts, and spleens. Congested lungs were also noticed. Surviving birds were positive for E.coli isolation from the liver and heart. No mortalities were recorded in the control group.
Antimicrobial Resistance Frequency
The frequency of resistance detected was highest against cefazolin (100%), streptomycin (98%), and ampicillin (96%), followed by doxycycline (90%), ciprofloxacin (82%), co-trimoxazole (66%), and gentamicin (45%), while all strains were susceptible to ertapenem.
Phenotypic ESBL and AmpC and Minimum Inhibitory Concentrations (MIC)
Three out of 50 (6%) isolates were resistant to cefotaxime or ceftazidime (MIC of ≥4 and ≥16 mg/L, respectively), but susceptible to combinations of cefotaxime or ceftazidime with clavulanic acid, and were identified as ESBL producing strains. Six strains (12%) were resistant to cefoxitin (MIC of ≥32 mg/L), but susceptible to a combination of cefoxitin and boronic acid, and were identified as AmpC producing strains. Data on MIC, resistance genes detected, and Table 2 .
PCR Screening and Sequencing
PCR analysis identified the 1,080 bp fragment of the bla TEM gene in all 6 AmpC producing isolates, and in just one ESBL producing isolate (4356). Sequencing of the entire nucleotide sequence from both strands and multiple sequence alignment of relevant protein sequence in comparison with that of bla TEM-1 (GenBank accession number J01749) in AmpC producing isolates, from codons 1 to 284, revealed 100% identical, while isolate 4356 revealed a G92D difference corresponding to bla TEM-57 (GenBank accession number FJ405211). PCR analysis with the bla SHV primers showed the presence of a 931 bp fragment only in the ESBL producing isolate 4356. Alignment of translated sequence from both strands (from first codon to codon 281) with amino acids sequence of bla SHV-1 gene (GenBank accession number AF148850) revealed differences at positions 35, 238, and 239, which most likely corresponds to bla (GenBank accession number AJ920369). PCR analysis with different bla CTX-M primers identified a 393 bp fragment of bla CTX-M group 9 in 2 ESBL strains (4363 and 4364). Sequence analysis within nucleotide range 146 to 669 detected 100% identity with bla CTX-M-14 (GenBank accession number AF252622). The sequence from both strands of PCR products of bla CMY gene in all AmpC strains and corresponding transconjugants within nucleotide range (517 to 937) showed 100% identical to the sequence of the respective segment of the bla CMY-2 gene (GenBank accession number X91840).
Transconjugation Assay
In 2 AmpC positive strains (4338 and 4340), the resistance traits could be mobilized into the Eco J53 recipient ( Table 2 ). The resulting transconjugants were assigned to the phylogenetic group A like the recipient Eco J53, but unlike both donors, which belonged to group D. bla CMY could be mobilized with a conjugation frequency of 10 −7 transconjugants per donor cell. The transconjugants displayed a typical AmpC phenotype consistent with that of the corresponding donors with resistance to cefotaxime, ceftazidime, and cefoxitine. It showed the same or a 2-fold higher MIC than the donors and was proven by PCR analysis to carry only the bla CMY gene (Table 2 ). It was notable that the resulting tranconjugants harbored class 1 integrons with the same amplicon size as the donors (one kb). Transfers were not successful for the other 4 AmpC or ESBL producing isolates, despite repeated attempts.
Prevalence of Class 1 Integrons
The presence of class 1 integrons was determined by use of PCR with the primers 5 -CS and 3 -CS for the amplifications of gene cassette regions, and their size was estimated. Amplicons ranging from 0.35 to 2.0 kb in length were found in 60% (30/50). Eight% (4/50), 4% (2/50), 8% (4/50), 8% (4/50), and 22% (11/50) of isolates integrated single gene cassettes 0.35, 1, 1.5, 1.7, and 2 kb in size, respectively, while 10% (5/50) of isolates contained double gene cassettes (0.7 + 1 or 1 + 1.7 kb). The largest amplicon was the most frequent. All ESBL, AmpC positive strains, and transconjugants harbored class 1 integrons. Two out of 3 (66.6%) and one out of 3 (33.3%) ESBL positive isolates integrated 1.5, 2 kb length gene cassettes, respectively, while 2 out of 6 with the corresponding transconjugants and 4 out of 6 (66.6%) AmpC positive strains harbored one kb and both 1 and 1.7 kb length gene cassettes, respectively.
Class 1 integrons were found among all 4 E. coli phylogenetic groups but with rates 1/4 (25%), 1/3 (33.3%), 9/17 (52.9%), and 19/26 (73%) for phylogroups A, B2, D, and B1, respectively (Table 1) .
Phylogenetic Groups
At 52% (26/50), B1 was the dominant phylogenetic group among the isolates, followed by group D at 34% (17/50); group A accounted for only 8% (4/50), and the extra-intestinal pathogenic group B2 for only 6% (3/50). All t3 ESBL producing strains belonged to group D, while AmpC producing strains belonged to phylogenetic groups B1 (4/6) and D (2/6) ( Table 1) .
AFLP Genotyping
A collated view of AFLP results and the respective phylogenetic group revealed a diversity of 28 different strains. Strains of different genotypes were found in 9 out of 15 farms with more than one isolate typed. In 8 instances, strains assigned to the same phylogroup and AFLP genotype were isolated from different farms raising different breeds. In 2 farms these were bla CMYpositive strains (Table 1) .
DISCUSSION
Antimicrobials are valuable tools to effectively defeat clinical diseases and to maintain healthy and productive birds. However, evidence shows that resistance is linked to antibiotic use, especially unrestricted usage (WHO, 2014) . Whole flocks are often treated at once, including birds that are not ill yet. This practice is very common in developing countries, where infections caused by enteric pathogens on poultry farms are severe and costly (Yang et al., 2004) . Moreover, antimicrobials are not only used when a disease strikes; they are also administered at sub-therapeutic doses to promote growth or to prevent diseases during times when birds may be susceptible to infections, or to assist in converting stress due to environmental changes and de-beaking, or as part of other management practices. Since most antibiotic classes used in veterinary medicine are the same as those used in humans, inappropriate use increases the reservoir of antibiotic resistant genes, particularly those in food animals, soil, and wastewater. The issue is under debate that resistance could be transferred to humans through the consumption of food, direct contact with birds, or through environmental spread, thereby running the risk of these resistant organisms developing the ability to withstand exposure even to lifesaving human antibiotics (Aidara-Kane, 2012; Chowdhury, 2014) . Antimicrobial resistance in diseased flocks impacts on the veterinary field by prolonging illness in animals; it leaves only few alternatives for the treatment of infections, increases production costs, and dramatically reduces income (Vaarten, 2012) . This is a huge problem for farms, whose activities are aimed at profit maximization, and at the same time is devastating to the whole poultry industry.
Colibacillosis in poultry farms is caused by Avian Pathogenic E. coli (APEC) and may occur as an acute fatal septicemia or subacute pericarditis, airsacculitis, salpingitis, or peritonitis. It can be seen as a secondary invader after viral infections. It is a common disease of economic importance in poultry keeping and is associated worldwide with morbidity and mortality of approximately 25 and 5%, respectively. The majority of economic losses are shared among the cost of treatment, mortality, lost production time, containment, and carcass disposal of the affected birds (Barnes et al., 2003) . Because of the significance of colibacillosis in the worldwide poultry industry, treatments with tetracyclines, penicillin, streptomycin, fluoroquinolones, and sulfonamides are primarily used to target E. coli, thus explaining the high level of multi-resistance of avian E. coli to these antibiotics (Yang et al., 2004; Zhao et al., 2005) .
Monitoring of drug usage in poultry farms is nonexistent in Egypt, especially with the lack of veterinary supervision on farms. We noticed that the economic losses brought on by severe and costly diseases like colibacillosis, and failure of antimicrobial treatment especially by fluoroquinolones and aminoglycosides, force some owners of small farms to turn to last resort antibiotics intended for human therapy. These include cefotaxime injection solutions, which is a third generation cephalosporin not permitted for use in poultry. Since third generation cephalosporins have been classified as critically important antimicrobials in human medicine by the World Health Organization (WHO, 2012), we investigated a collection of multi-resistant E. coli strains isolated from diseased chickens with colibacillosis for ESBL and AmpC production. This was done because development of antimicrobial resistance against third generation cephalosporins in food producing animals is a major public health concern, especially in view of the high probability that resistance will be transferred to humans.
In accordance with Schouler et al., the selected strains were pathogenic, whereby the pathogenicity index value was at least two. Furthermore, susceptibility data revealed higher resistance rates for cefazolin, streptomycin, ampicillin, and doxycycline, presumably due to long-term use of these antimicrobials in veterinary practice or cross resistance among antibiotics of the same class, such as doxycycline, since oxytetracycline is commonly fed in sub-therapeutic doses for growth promotion purposes. Previous studies confirming our findings recorded a high degree of antimicrobial resistance in E. coli in Egypt, both in humans (Abo-State et al., 2012; Khater and Sherif, 2014) , food of animal origin (Aly et al., 2012) , and broiler chickens (Mohamed et al., 2014) , highlighting the fact that antimicrobial resistance is widespread in Egypt. Furthermore, ESBL producing isolates are usually crossresistant to other antibiotics such as aminoglycosides, tetracyclines, chloramphenicol, trimethoprim, sulfonamides, or quinolones, often due to the presence of different resistance genes on mobile genetic elements such as plasmids, transposons, or integrons (Machado et al., 2005) .
In this study, we addressed repeated complaints from commercial broiler farms facing the effects of treatment failure of their flocks. We detected ESBL and AmpC producing E. coli strains in the diseased broilers investigated, and assumed either a co-selection under ß-lactam or non-ß-lactam antibiotic pressure (Laube et al., 2013) or initial contamination of farms due to insufficient cleaning and disinfection (Hiroi et al., 2012) , especially because ESBL producing E. coli were previously detected in ambient air indoors and outdoors, soil surfaces in the areas surrounding the poultry farms, slurry, and even in-house flies inside chicken houses (Laube et al., 2014; Blaak et al., 2014) . ESBL or AmpC producing E. coli were not detected in all of the broiler farms investigated or in all of the 4 cities screened, unlike another study, which isolated ESBL/AmpC producing E. coli from all of the 50 Dutch broiler farms investigated (Huijbers et al., 2014) . Concerning the ESBL producing strains, the 2 farms sampled were located in different villages, albeit in the same governorate, which is about 1,442 km 2 in size and is located approximately halfway between Port Said to the north and Suez to the south. Concerning the AmpC producing strains, the sampled farms were located in different cities (Ismailia and Port Said) and raised different breeds (Avian and Hubbard). This fact directed our thinking to the non-prudent use of antimicrobials, a possible common source of infection inside the same city and the hygienic measures applied in poultry farms.
The ESBL and AmpC gene families identified showed distributions with bla CTX-M-14 and bla CMY-2 to be most prevalent in 2 and 6 strains, respectively. bla CTX-M variants previously isolated from chickens include bla CTX-M-1 (the most prevalent variant), bla CTX-M-2 , bla , and bla CTX-M-15 (Randall et al., 2011) . These represent a potential threat to human health, since bla 15 and 27 ESBLs have already been reported in human E. coli isolates in Egypt (Mohamed Al-Agamy et al., 2006) . The resistance genes bla TEM , bla SHV , and bla CMY have been reported from Egypt in a collection of Enterobacteriaceae recovered from diarrheic calves (Ahmed et al., 2009) , mastitic cows (Ahmed and Shimamoto, 2011) , septicemic broilers (Ahmed et al., 2013) , and humans (Al-Agamy, 2013; Fam, 2013) . The collective data from the available studies reveal considerable similarity among ESBL and AmpC types recovered from chickens and humans in Egypt, raising the question to what extent chickens as a food source contribute to the spread of expanded spectrum β-lactamases in humans.
The conjugation experiments showed that the bla CMY-2 genes found in 2 strains with 2 different genotypes were located on conjugative plasmids linked with class 1 integrons, but without bla TEM-1 . The same results were recorded earlier (Zhao et al., 2001; Machado et al., 2005; Ben Sallem et al., 2014) . This could suggest that bla CMY-2 can readily spread in E. coli, causing horizontal dissemination. Yet, in accordance with other studies (Khalaf et al., 2009; Kim et al., 2011) , a conjugal transfer of the bla CTX-M-14 or bla or bla SHV-12 determinants was not detectable, indicating that those determinants may be encoded in plasmids that do not possess the genes required for conjugation.
The presence of integrons among clinical avian E. coli isolates is commonly connected to multiple-antibiotic resistance (Bass et al., 1999) . In our study, class 1 integrons were detected in varying sizes, and totaled 60%, which is consistent with previous data in China (Yang et al., 2004) , but higher than 46.6% detected earlier in Egypt (Ahmed et al., 2013) . Class 1 integrons were detected earlier in E. coli isolates and they contained genes for resistance to aminoglycosides (Yang et al., 2004) , trimethoprim, quinolones (Wang et al., 2003) , and β-lactams, encoding e.g. bla CTX-M or bla CMY (Chang et al., 2000) , which supports our results. Previous studies have shown an association of ESBL genes with plasmids from bacteria responsible for nosocomial outbreaks and associated with class 1 integrons (Villa et al., 2000) . Furthermore, and in accordance with others (Machado et al., 2008) , we found a high occurrence of class 1 integrons (100%) in different isolates harboring bla TEM or bla SHV or bla CTX-M or bla CMY genes, which in turn highlights the role of integrons both in terms of the mechanisms of resistance and in the dissemination of resistance genes.
Phylogenetic groups are associated with virulence factors and the risk of causing various infections (Gordon et al., 2008) , because human virulent strains causing extra-intestinal infections belong mainly to groups B2 and D, whereas strains from groups A and B1 are less often recovered from extra-intestinal body sites (Kluytmans et al., 2013) . They predominate among poultry sources, whereby E. coli phylogroups B2 and D isolated from broiler chicken meat or broiler chickens are associated with human urinary tract infection (Jakobsen et al., 2010a) . In concordance with previous studies (Dhanji et al., 2010; Reich et al., 2013) , we found that ESBL strains belonged to phylogroup D, while AmpC strains belonged to phylogroups B1 and D. Furthermore, some avian and human ExPEC have similar phylogenic backgrounds and share virulence genes (Manges and Johnson, 2012) , which might lead to the assumption that resistant group D isolates from chickens contribute to the dissemination of resistance in humans.
In agreement with others (Geornaras et al., 2001; Olsen et al., 2014) , AFLP genotyping results showed heterogeneity and genetic diversity in 9 farms located in 4 cities. This suggests that the multi-resistant E. coli isolates investigated in this study were not derived from the spread of a specific clone; rather, they represented a wide variety of different genotypes (Dai et al., 2008) . The 3 ESBL producing E. coli isolates were from 2 different farms, and genotyping by AFLP revealed that they were clonally unrelated to each other. The 6 AmpC producing isolates on the other hand were from 4 different farms, but AFLP analysis revealed a clonal relatedness in 4 of the isolates from 2 farms with different breeds of chickens. These findings support the role of both horizontal transfer of mobile genetic elements and clonal dissemination, presumably from external sources such as food, day-old chicks, and incorrect cleaning and disinfection (Cameron-Veas et al., 2015) , as the major driving forces behind any future spread of antimicrobial resistance patterns between flocks and regions in Egypt.
A limitation of this study was the small number of isolates investigated and the lack of epidemiological linkages to parallel human isolates from the sampled region.
In conclusion, surveillance studies in developing countries, where antibiotic usage is highest and thus poses a global challenge, could give more insights into and information about antimicrobial resistance in Gram-negative bacteria. This study highlights the emergence of expanded spectrum β-lactamase producing E. coli isolates among diseased chickens in Egypt, where drug misuse is not excluded. The occurrence of bla CTX-M-14 and bla CMY-2 genes underlines the possibility of spread of such strains to humans. To retain critically important antimicrobials as treatment options, there is, as suggested by our results, a need for longterm surveillance of antimicrobial usage and resistance in Egypt, not just in human medicine, but also among food producing animals, and especially chickens, which are favored for consumption because of their relatively low price as compared with red meats.
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